N-(3-chloro-4-fluorophenyl)-1-(cyclopentylsulfonylamino)-7-fluoro-2,3-dihydro-1H-indene-4-carboxamide
C21H21ClF2N2O3S — CID 153315393
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(3-chloro-4-fluorophenyl)-1-(cyclopentylsulfonylamino)-7-fluoro-2,3-dihydro-1H-indene-4-carboxamide
N-(3-chloro-4-fluorophenyl)-1-(cyclopentylsulfonylamino)-7-fluoro-2,3-dihydro-1H-indene-4-carboxamide (PubChem CID 153315393) has the molecular formula C21H21ClF2N2O3S and a molecular weight of 454.93 g/mol. Its IUPAC name is N-(3-chloro-4-fluorophenyl)-1-(cyclopentylsulfonylamino)-7-fluoro-2,3-dihydro-1H-indene-4-carboxamide.
Molecular Properties
| Compound Name | N-(3-chloro-4-fluorophenyl)-1-(cyclopentylsulfonylamino)-7-fluoro-2,3-dihydro-1H-indene-4-carboxamide |
|---|---|
| PubChem CID | 153315393 |
| Molecular Formula | C21H21ClF2N2O3S |
| Molecular Weight | 454.93 g/mol |
| Exact Mass | 454.09 |
| IUPAC Name | N-(3-chloro-4-fluorophenyl)-1-(cyclopentylsulfonylamino)-7-fluoro-2,3-dihydro-1H-indene-4-carboxamide |
| SMILES | O=C(Nc1ccc(F)c(Cl)c1)c1ccc(F)c2c1CCC2NS(=O)(=O)C1CCCC1 |
| InChI | InChI=1S/C21H21ClF2N2O3S/c22-16-11-12(5-8-17(16)23)25-21(27)15-6-9-18(24)20-14(15)7-10-19(20)26-30(28,29)13-3-1-2-4-13/h5-6,8-9,11,13,19,26H,1-4,7,10H2,(H,25,27) |
| InChIKey | XJXCCJFYQPCWII-UHFFFAOYSA-N |
| XLogP | 4.72 |
| TPSA | 75.27 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 454.93 |
| LogP ≤ 5 | 4.72 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153315393 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.